ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 66 | 1,778 | 963 | 7 | 23 |
| Gross Profit | 66 | 1,778 | 963 | 7 | 23 |
| Operating Expenses | 1,329 | 2,253 | 1,764 | 1,502 | 1,126 |
| Operating Income | -1,264 | -475 | -801 | -1,495 | -1,103 |
| Other Income | 19 | 64 | 0 | 0 | 0 |
| Pre-tax Income | -1,245 | -411 | -801 | -1,495 | -1,103 |
| Net Income Continuous | -1,245 | -411 | -801 | -1,495 | -1,103 |
| Net Income | $-1,245 | $-411 | $-801 | $-1,495 | $-1,103 |
| EPS Basic Total Ops | -5.04 | -0.72 | -3.96 | -7.92 | -5.76 |
| EPS Basic Continuous Ops | -4.96 | -0.59 | -3.91 | -7.93 | -5.85 |
| EPS Diluted Total Ops | -5.04 | -0.72 | -3.96 | -7.92 | -5.76 |
| EPS Diluted Continuous Ops | -4.96 | -0.59 | -3.91 | -7.93 | -5.85 |
| EBITDA(a) | $-1,240 | $-452 | $-778 | $-1,473 | $-1,080 |